CORRECTION article

Front. Nutr., 04 January 2023

Sec. Nutrition and Microbes

Volume 9 - 2022 | https://doi.org/10.3389/fnut.2022.1109835

Corrigendum: Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents

  • 1. INRAE, UMR 1019, Unité de Nutrition Humaine, Université Clermont Auvergne, Clermont-Ferrand, France

  • 2. Université Paris-Saclay, INRAE UMR 1319, AgroParisTech, Micalis Institute, Jouy-en-Josas, France

  • 3. INRAE UMR 0545, Unité Mixte de Recherche sur le Fromage, Université Clermont Auvergne, VetAgro Sup, Aurillac, France

Article metrics

View details

1,1k

Views

517

Downloads

In the published article, there was an error in the legend for Figure 6A as published. The title on Y-axis is “Protein content in hindlimb muscle (mg/g).” The corrected legend appears below.

Figure 6

Figure 6

Levels of protein, insulin pathway mediators, and proteolysis-related gene expression in the muscles of 18-month-old rats fed an ad libitum (AL) diet or a food-restricted (R) diet over a one-month period; one food-restricted group received a probiotic supplement – strain 63 (R+63). (A) Protein levels in hindlimb muscles (gastrocnemius, soleus, tibialis anterior, and extensor digitorum longus). (B) Levels of proteins involved in the AKT/mTOR/S6K pathway: ratio of phosphorylated proteins, p-S6 (Ser235/236), and p-eIF2α (Ser51), to total proteins, S6 and eIF2α. (C) Expression levels of muscle proteolysis genes, namely those related to the regulation of the ubiquitin-proteasome-dependent pathway (Atrogin-1 and MuRF-1) and autophagy pathway (Lc3b, ATG16L, and Cathepsin L). Values are means ± SEM. Differences in letters indicate a significant difference between groups (Kruskal–Wallis test and Dunn's post hoc test, p ≤ 0.05, n = 61 rats).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

muscle, sarcopenia, probiotic, lactic acid bacteria, insulin sensitivity, protein synthesis

Citation

Giron M, Thomas M, Jarzaguet M, Mayeur C, Ferrere G, Noordine M-L, Bornes S, Dardevet D, Chassard C and Savary-Auzeloux I (2023) Corrigendum: Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents. Front. Nutr. 9:1109835. doi: 10.3389/fnut.2022.1109835

Received

28 November 2022

Accepted

29 November 2022

Published

04 January 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Isabelle Savary-Auzeloux ✉

This article was submitted to Nutrition and Microbes, a section of the journal Frontiers in Nutrition

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics